AnalystsDelma Caiati
Delma Caiati's Stock Forecasts

Analyst Ranking
Bottom 27%
#4128 out of 5565 analysts
Average Return
-1.16%
Win Rate
33%3 out of 9
Risk vs Reward
Poor
Good

Delma Caiati's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Lb Pharmaceuticals IncLBRX
+16.87%$34.26$40.04
2026-10-06 -
2026-11-19
Strong Buy
Neurocrine Biosciences IncNBIX
+7.61%$145.51$156.59
2026-10-06 -
2026-11-19
Strong Buy
Xenon Pharmaceuticals IncXENE
+2.71%$36.57$37.56
2026-10-06 -
2026-11-19
Strong Buy
Ovid Therapeutics IncOVID
0.00%$2.34$2.34
2026-10-05 -
2026-11-19
Strong Buy

Delma Caiati Analyst Color

Get additional color on Delma Caiati's coverage of popular stocks

Delma Caiati's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Rapport Therapeutics IncRAPP
3Strong Buy$66.00+179.78%Maintains
15 days ago
Neurocrine Biosciences IncNBIX
2Strong Buy$224.00+43.05%Maintains
16 days ago
Lb Pharmaceuticals IncLBRX
1Strong Buy$80.00+99.80%Initiates Coverage On
a month ago
Xenon Pharmaceuticals IncXENE
1Strong Buy$73.00+94.36%Assumes
a month ago
Ovid Therapeutics IncOVID
2Strong Buy$7.00+199.15%Initiates Coverage On
a month ago
Maplight Therapeutics IncMPLT
1HoldN/AN/AInitiates Coverage On
a month ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.